Mitcham Inds Inc (MIND) 3.36 $MIND Mitcham Industries

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mitcham Inds Inc (MIND) 3.36 $MIND

Mitcham Industries Declares Cash Dividend on its 9.00% Series A Cumulative Preferred Stock
PR Newswire - Thu Jul 14, 6:00AM CDT
Mitcham Industries, Inc. ("Mitcham" or the "Company" (Nasdaq: MIND) announced today that it has declared a quarterly cash dividend on its 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock" for the pro-rated second quarter of the fiscal year ending January 31, 2017.
MIND: 3.36 (-0.08)

Mitcham Industries Reports Fiscal 2017 First Quarter Results
PR Newswire - Wed Jun 08, 3:15PM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) ("the Company" today announced financial results for its fiscal 2017 first quarter ended April 30, 2016.
MIND: 3.36 (-0.08)

Mitcham Industries Announces Fiscal 2017 First Quarter Earnings Release And Conference Call Schedule
PR Newswire - Wed Jun 08, 6:45AM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2017 first quarter ended April 30, 2016 after the market closes on Wednesday, June 8, 2016. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Thursday, June 9 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 3.36 (-0.08)

Mitcham Industries Prices Public Offering of 9.00% Series A Cumulative Preferred Stock
PR Newswire - Thu Jun 02, 5:00PM CDT
Mitcham Industries, Inc. ("Mitcham" or the "Company" (Nasdaq: MIND) announced today that it has priced an underwritten public offering of 320,000 shares of 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock" at a price of $25.00 per share, pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (the "SEC". In addition, Mitcham has granted the underwriter a 30-day option to purchase from it an additional 48,000 shares of Series A Preferred Stock. Dividends on the Series A Preferred Stock will be payable from and including the date of original issue at a rate of 9.00% per annum of the $25.00 per share liquidation preference (equivalent to $2.25 per annum per share). The offering is expected to close on or about June 8, 2016, subject to customary closing conditions
LTS: 2.44 (-0.01), MIND: 3.36 (-0.08)

Mitcham Industries Commences Public Offering of 9.00% Series A Cumulative Preferred Stock
PR Newswire - Wed May 18, 11:02AM CDT
Mitcham Industries, Inc. ("Mitcham" or the "Company" (Nasdaq: MIND) announced today that it has commenced an underwritten public offering of 600,000 shares of 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock" at a price of $25.00 per share, pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (the "SEC". In addition, Mitcham expects to grant the underwriter a 30-day option to purchase from it an additional 90,000 shares of Series A Preferred Stock.
LTS: 2.44 (-0.01), MIND: 3.36 (-0.08)

Mitcham Industries Reports Fiscal 2016 Fourth Quarter And Full Year Results
PR Newswire - Tue Apr 05, 3:15PM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or the "Company" today announced financial results for its fiscal 2016 fourth quarter and full year ended January 31, 2016.
MIND: 3.36 (-0.08)

Mitcham Industries Announces Fiscal 2016 Fourth Quarter And Year-End Earnings Release And Conference Call Schedule
PR Newswire - Tue Apr 05, 6:00AM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2016 fourth quarter and year-end ended January 31, 2016 after the market closes on Tuesday, April 5, 2016. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Wednesday, April 6 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 3.36 (-0.08)

3 Sectors to Avoid as China Stock Market Takes a Bumpy Ride
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 3:53PM CST
This time not only did the Chinese investors suffer -- stakeholders all over the world felt the heat of this market slump.
ALNY: 68.08 (-0.21), BVN: 14.65 (+0.50), OCRX: 2.60 (-0.05), IPI: 1.29 (+0.02), MIND: 3.36 (-0.08), HELI: 3.67 (-0.33)

Mitcham Industries Acquires L-3 Communications Klein Associates
PR Newswire - Mon Jan 04, 3:15PM CST
Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or "the Company" announced today that it has acquired L-3 Communications Klein Associates, Inc. ("Klein", a designer, manufacturer and worldwide distributor of sonar and waterside security systems to military and commercial customers. Klein was a wholly-owned subsidiary of L-3 Communications Corporation, a leading provider of a broad range of communication and electronic systems and products used on military and commercial platforms, and a prime contractor in aerospace systems.
MIND: 3.36 (-0.08)

Mitcham Industries Reports Fiscal 2016 Third Quarter Results
PR Newswire - Tue Dec 08, 3:15PM CST
Mitcham Industries, Inc. (NASDAQ: MIND) ("the Company" today announced financial results for its fiscal 2016 third quarter ended October 31, 2015.
MIND: 3.36 (-0.08)

Mitcham Industries Announces Fiscal 2016 Third Quarter Earnings Release And Conference Call Schedule
PR Newswire - Tue Dec 08, 6:45AM CST
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2016 third quarter ended October 31, 2015 after the market closes on Tuesday, December 8, 2015. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Wednesday, December 9 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 3.36 (-0.08)

/C O R R E C T I O N -- Mitcham Industries, Inc./
PR Newswire - Tue Nov 10, 10:00AM CST
In the news release, Mitcham Industries Announces Fiscal 2016 Third Quarter Earnings Release And Conference Call Schedule, issued 10-Nov-2015 by Mitcham Industries, Inc. over PR Newswire, we are advised by the company that the When section, should read "Wednesday, December 9, 2015 at 9:00 a.m. Eastern / 8:00 a.m. Central" rather than "Thursday, December 3, 2015 at 9:00 a.m. Eastern / 8:00 a.m. Central" as originally issued inadvertently. The complete, corrected release follows:
MIND: 3.36 (-0.08)

SCANA (SCG) Rate Hike Okayed for South Carolina Customers
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 3:10PM CDT
SCANA Corporation (SCG) announced that the Public Service Commission of South Carolina (SCPSC) has approved a $64.5 million rate hike.
BAK: 11.50 (+0.10), ALDW: 9.78 (+0.68), SCG: 74.94 (+1.00), MIND: 3.36 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading